Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group

Clinical and Experimental Immunology

Volumn 190, Issue 2, 2017, Pages 226-234

  Jolles, S ^a   Sanchez Ramon S ^b   Quinti, I ^c   Soler Palacin P ^d   Agostini, C ^e   Florkin, B ^f   Couderc, L J ^g   Brodszki, N ^h   Jones, A ⁱ   Longhurst, H ^j   Warnatz, K ^k   Haerynck, F ^l   Matucci, A ^m   de Vries, E ^n,o  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^j BARTS HEALTH NHS TRUST   (United Kingdom)

^k UNIVERSITY OF FREIBURG   (Germany)

^l GHENT UNIVERSITY HOSPITAL   (Belgium)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ JEROEN BOSCH HOSPITAL   (Netherlands)

^o TILBURG UNIVERSITY   (Netherlands)

more..

Author keywords

antibody deficiency; lung disease; monitoring; primary immunodeficiency disease; subclinical infection

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G; RITUXIMAB; STEROID; IMMUNOGLOBULIN;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BRONCHIECTASIS; CHILD; CLINICAL PROTOCOL; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE SEVERITY; EUROPE; EXERCISE TEST; HEALTH SURVEY; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; LABORATORY TEST; LUNG COMPLICATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; SCREENING; SPIROMETRY; AGAMMAGLOBULINEMIA; AMBULATORY CARE; ASYMPTOMATIC INFECTIONS; COMPLICATION; FEMALE; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; LUNG DISEASES; MALE; MEDICAL RECORD; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RESPIRATORY SYSTEM;

ADULT; AGAMMAGLOBULINEMIA; AMBULATORY CARE; ASYMPTOMATIC INFECTIONS; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; EUROPE; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LUNG DISEASES; MALE; MEDICAL RECORDS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; SPIROMETRY;

EID: 85028303819     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.13012     Document Type: Article

References (30)

1. Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr 2014; 2:77.
2. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34–48.
3. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J Allergy Clin Immunol Pract 2013; 1:545–56.
4. Jolles S. Subclinical infection and dosing in primary immunodeficiencies. Clin Exp Immunol 2014; 178:67–9.
5. Quinti I, Soresina A, Spadaro G et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308–16.
6. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119:1650–7.
7. Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999; 159:1199–204.
8. Kainulainen L, Suonpaa J, Nikoskelainen J et al. Bacteria and viruses in maxillary sinuses of patients with primary hypogammaglobulinemia. Arch Otolaryngol Head Neck Surg 2007; 133:597–602.
9. Kainulainen L, Vuorinen T, Rantakokko-Jalava K, Osterback R, Ruuskanen O. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 2010; 126:120–6.
10. Duraisingham SS, Hanson S, Buckland M, Grigoriadou S, Longhurst HJ. Pseudomonas infection in antibody deficient patients. Eur J Microbiol Immunol (Bp) 2014; 4:198–203.
11. Duraisingham SS, Manson A, Grigoriadou S, Buckland M, Tong CY, Longhurst HJ. Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol 2015; 181:267–74.
12. Guillerman RP. Imaging of childhood interstitial lung disease. Pediatr Allergy Immunol Pulmonol 2010; 23:43–68.
13. Odegard KC, DiNardo JA, Tsai-Goodman B, Powell AJ, Geva T, Laussen PC. Anaesthesia considerations for cardiac MRI in infants and small children. Paediatr Anaesth 2004; 14:471–6.
14. Seed L, Wilson D, Coates AL. Children should not be treated like little adults in the PFT lab. Respir Care 2012; 57:61–70.
15. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190–7.
16. Eijkhout HW, van den Broek PJ, van der Meer JW. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med 2003; 61:213–7.
17. Immune Deficiency Foundation (IDF). Diagnostic and clinical care guidelines for primary immunodeficiency diseases. Towson, MD: IDF, 2009.
18. Moschese V, Martire B, Soresina A et al. Anti-infective prophylaxis for primary immunodeficiencies: what is done in Italian Primary Immunodeficiency Network centers (IPINet) and review of the literature. J Biol Regul Homeost Agents 2013; 27:935–46.
19. Italian Primary Immunodeficiencies Strategic Scientific Committee. Common variable immunodeficiency, recommendations for diagnosis and treatment. Bologna, Italy: Centro Operativo AIEOP, 2004
20. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116:7–15.
21. Hernandez-Trujillo HS, Chapel H, Lo Re V III et al. Comparison of American and European practices in the management of patients with primary immunodeficiencies. Clin Exp Immunol 2012; 169:57–69.
22. O'Shaughnessy D, Hollingsworth R, Kane P, Foster M. Third National Immunoglobulin Database Report (2012). Manchester, UK: Medical Data Services and Solutions, 2013.
23. Seeborg FO, Seay R, Boyle M, Boyle J, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol 2015; 35:638–50.
24. Quinti I, Soresina A, Guerra A et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011; 31:315–22.
25. Maarschalk-Ellerbroek LJ, de Jong PA, van Montfrans JM et al. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol 2014; 34:642–54.
26. Kuo W, Ciet P, Tiddens HA, Zhang W, Guillerman RP, van Straten M. Monitoring cystic fibrosis lung disease by computed tomography. Radiation risk in perspective. Am J Respir Crit Care Med 2014; 189:1328–36.
27. Stiehm ER. The four most common pediatric immunodeficiencies. J Immunotoxicol 2008; 5:227–34.
28. Hill AT, Routh C, Welham S. National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care? Thorax 2014; 69:292–4.
29. Chalmers JD, Goeminne P, Aliberti S et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 2014; 189:576–85.
30. Martinez-Garcia MA, de Gracia J, Vendrell Relat M et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J 2014; 43:1357–67.